Clinical trial NCT05205434: Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges
Official title: Efficacy of Synchronous and Asynchronous Telerehabilitation in COVID-19 Discharges
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: COVID-19
Telerehabilitation
Keywords: COVID-19
Telerehabilitation
Exercise program
Breathing exercises
Lead sponsor: Bitlis Eren University
Sponsor class: OTHER
Collaborators: name: Marmara University
First posted: 2022-01-25
Enrollment: 57
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomized Controlled Study
Primary purpose: TREATMENT

Brief summary: Investigators aimed to evaluate the effectiveness of exercise programs given by synchronous and asynchronous telerehabilitation methods in patients after discharge from COVID-19.

Detailed description: Fifty seven participants will be enrolled. Participants will be randomly divided into 3 groups.

For this purpose, patients will be recruited at the time of discharge from the hospital and two experimental groups with the same physical therapy and educational program will be carried out. participants in the control group will only educational program. Participants in experimental groups will be followed using videoconference interviews from synchronous telerehabilitation methods and mobile application from asynchronous telerehabilitation methods at home. These participants will be given an 8-week exercise program. The exercise program will consist of physical exercises (aerobic and strength exercises) along with breathing exercises and the patients will be evaluated before and after the treatment.

After treatment programs, the functional capacity, performance, and hemodynamic parameters of the participants will be evaluated. Quality of life, physical activity level, anxiety-depression, and fatigue severity will also be evaluated with questionnaires.

Eligibility criteria: Inclusion Criteria:

* COVID-19 patients in the subacute period discharged
* Be 18 years or older
* Having received oxygen therapy or mechanical ventilation support in the hospital
* Access to online interviews and web-based exercises with a secure internet connection
* Having sufficient speaking and hearing skills for telerehabilitation
* Volunteer to participate in research

Exclusion Criteria:

* Unstable clinical condition
* Having had cerebrovascular disease, intra-articular drug injection or surgery of the lower extremities in the last 6 months
* Inability to walk independently, even with an assistive device
* Having serious neuromuscular problems
* Not being cooperative enough to answer and understand questionnaires and scales

Primary outcomes:
measure: Incremental Shuttle Walk Test (ISWT)
timeFrame: Change from baseline walking distance (meters) of the patients at the end of the 8th week and, postintervation sixth months
Secondary outcomes:
measure: 30-Second Chair Stand Test (30 CST)
timeFrame: Change from baseline number of sitting and staying of the patients at the end of the 8th week and, postintervation sixth months
measure: Brief Physical Performance Battery (BPPB)
timeFrame: Change from baseline score of the patients at the end of the 8th week and, postintervation sixth months
Other outcomes:
measure: Oxygen Saturation and Heart Rate
timeFrame: Change from baseline oxygen saturation (SaO2) and heart rate (beats per minute) of the patients at the end of the 8th week and, postintervation sixth months
measure: Dyspnea and Fatigue Level
timeFrame: Change from baseline dyspnea and fatigue of the patients at the end of the 8th week and, postintervation sixth months
measure: Timed Up-Go Test (TUG)
timeFrame: Change from baseline time (second) of the patients at the end of the 8th week and, postintervation sixth months
measure: International Physical Activity Questionnaire Short Form (IPAQ)
timeFrame: Change from baseline metabolic equivalent (MET)-minute/week of the patients at the end of the 8th week and, postintervation sixth months
measure: Hospital Anxiety Depression (HAD) Scale
timeFrame: Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months
measure: Fatigue Severity Scale
timeFrame: Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months
measure: Quality of Life Scale: Short Form-36 (SF-36)
timeFrame: Change from baseline score in scale of the patients at the end of the 8th week and, postintervation sixth months
Locations:
city: Maltepe
country: Turkey
facility: Marmara University
state: İstanbul
Study officials:
affiliation: Bitlis Eren University
name: Abdurrahman TANHAN, MSc
role: PRINCIPAL_INVESTIGATOR
References: